Oral Vitamin D May Help Prevent Some Skin Infections Oct 8, 2008
29, 1998) In the first study of its kind in children, tacrolimus, used to fight organ rejection, has been found to combat atopic dermatitis in children. We ve had patients that after four days of. (Science Daily)
Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets Aug 28, 2008
e., daclizumab, tacrolimus, and sirolimus). After the second islet transplantation, the. (New England Journal of Medicine)
Canine Pemphigus Aug 27, 2008
Topical corticosteroids and tacrolimus are also used. In cats, chloramphenicol is used in place of azathioprine. (Suite101.com)
Facial Transplantation Shows Promise for Severe Disfigurement Aug 26, 2008
The subject's immunomodulatory regimen included tacrolimus, mycophenolate mofetil, corticosteroids, and humanized IL-2 receptor monoclonal antibody ... The patient's immunosuppressive regimen included antilymphocyte serum, tacrolimus, mycophenolate mofetil, and prednisone. (RMGH Health News)
Immune Response May Hinder Stem Cell Treatments Aug 19, 2008
Medicating the mice with normal immune systems with a combination of two common anti-rejection compounds -- tacrolimus and sirolimus -- allowed those cells to survive for up to 28 days, the team said. More information. (U.S. News & World Report)
Immune Response To Human Embryonic Stem Cells In Mice Suggests Human Therapy May Face Challenge Aug 19, 2008
They found that a combination of two compounds - tacrolimus and sirolimus - allowed the cells to survive for up to 28 days in the mice with normal immune systems. Wu and his colleagues will continue to investigate whether different combinations can more effectively mitigate the immune response in mice. (Science Daily)
Revolutionary Technique Could Reduce Lifelong Drugs For Transplant Patients Aug 7, 2008
Medical staff were then able to wean six of them down to low-dose tacrolimus monotherapy, which is a much less intrusive drug regime with fewer side effects ... One patient was able to go eight months without any immunosuppression drugs and a further three were successfully weaned from a conventional immunosuppression regime to low-dose tacrolimus monotherapy. (Science Daily)
'Multi-target' immune therapy improves outcomes of severe lupus nephritis Jul 2, 2008
One group of patients received this "multi-target" therapy, consisting of the immunosuppressant drugs tacrolimus and mycophenolate mofetilcommonly used as anti-rejection drugs in transplant patientsplus a steroid. The other group received standard treatment with a single immunosuppressant drug (cyclophosphamide). (EurekAlert!)
Kidney Transplant Patients May Benefit From Going Off Of Certain Immunosuppressive Drugs Jun 25, 2008
Other commonly used regimens include a calcineurin inhibitor such as cyclosporine or tacrolimus, plus mycophenolate mofetil and steroids ... 1% of patients taking tacrolimus plus mycophenolate mofetil and steroids ... 92 for patients in the tacrolimus group. (Science Daily)
A Man with Headache and Visual Changes after Liver Transplantation Jun 12, 2008
Tacrolimus, azathioprine, furosemide, spironolactone, and a short course of corticosteroids were administered postoperatively. The immediate postoperative course was complicated by coagulopathy, intraperitoneal thrombi, and worsening renal function, with ascites and peripheral edema. (New England Journal of Medicine)
No Racial Gap Seen in Liver Transplant Results Jun 7, 2008
The authors believe that much of the credit in equalizing outcomes goes to the introduction of the drug tacrolimus to prevent rejection of transplanted organs. Dr. Johnny C. Hong from the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues analyzed data on 817 patients who underwent transplantation between 1984 and 1993, when cyclosporine was the main anti-rejection agent, and on 1922 patients transplanted between 1994 and 2007 when tacrolimus was the... (MEDLINEplus)
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation Jun 5, 2008
The authors' putative conclusion is that a quadruple immunosuppressive regimen of daclizumab, "low-dose" tacrolimus, mycophenolate mofetil, and corticosteroids should be considered the standard in renal transplantation. We have concerns, however, about the equipotency of the four immunosuppressive strategies used. (New England Journal of Medicine)
Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function Jun 2, 2008
Baseline characteristics and measured GFR values were similar in the treatment groups and 98 patients in the CellCept-based regimen in combination with SRL were receiving tacrolimus. Graft loss was experienced in 1. (PR Newswire)
Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients Jun 2, 2008
07) was observed for ELISA-PRA class I. Three different patterns were evident among the renal transplant patients: -- Those in whom the immune function values were in a stable zone (100-300 ng ATP/mL) with or without anti-HLA antibodies -- Those who exhibited diminished levels of immune function ( (1) Tan HP, Donaldson J, Basu A, et al. 411 Living donor kidney transplants using alemtuzumab pre-conditioning and tacrolimus monotherapy: 5 year experience ... (2) Tan HP, Donaldson J, Basu A, et al.... (PR Newswire)
Drug may prolong organ life in noncompliant kidney transplant patients May 31, 2008
Co-authors of the study, "Sirolimus (SRL) Blunts Mitogen Response at Trough (C0) Levels More Than Cyclosporin (CSA) or Tacrolimus (TAC): A Safeguard for Our Many Long Term Noncompliant Kidney Transplant Patients (KTPs)" include UC San Diego School of Medicine physicians Nitin Khosla M.D., and Rodolfo Batarse, M.D., assistant professor of medicine. About ATC. (EurekAlert!)
Preventive Treatment Curbs Eczema Flare-Ups May 30, 2008
NEW YORK (Reuters Health) - Among adults with eczema, otherwise known as atopic dermatitis, "proactive" long-term treatment with tacrolimus ointment applied twice-weekly safely reduces exacerbations of the condition, European investigators have shown ... Dr. Andreas Wollenberg, from Ludwig-Maximilian Universitat in Munich, Germany, and members of the European Tacrolimus Ointment Study Group conducted a clinical trial in which 247 adult patients with atopic dermatitis initially applied tacrolimus... (MEDLINEplus)
Isotechnika reports final results of the PROMISE trial May 27, 2008
"PROMISE has shown that the efficacy of voclosporin is statistically non-inferior when compared to the market leader, tacrolimus in all three dose groups," stated Dr. Robert Foster, Isotechnika's Chairman "While matching tacrolimus in efficacy, key safety advantages such as a lower incidence of new onset diabetes mellitus (NODM) and preservation of kidney function were shown. In addition to highlighting these key safety advantages, the wide therapeutic window was confirmed. This window will... (Canada Newswire)
Immunosuppressant Further Linked To Birth Defects, Case Study Suggests Feb 13, 2008
Following the second transplant she took the immunosuppressant drugs tacrolimus and MMF. Two years later she became pregnant and MMF was discontinued at 10 weeks gestation, while tacrolimus, one of the drugs that has been studied in pregnant women, was maintained. She delivered a female infant who had cleft lip and palate, as well as defects of the jaw, eyes and ears, including no external ear canals. (Science Daily)
FDA Approves Additional Indication for Astellas' MYCAMINE(R) Jan 23, 2008
MYCAMINE can be used concomitantly with a number of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus with no alteration in the pharmacokinetics of MYCAMINE. Patients should be monitored for sirolimus, nifedipine or itraconazole toxicity if receiving these drugs in combination with MYCAMINE and their dosage reduced, if necessary. MYCAMINE is available in two sizes, 50mg vial and 100mg vial, offering clinicians convenience of... (PR Newswire)
Grapefruit bad medicine with some drugs Dec 4, 2007
Some of the drugs that fall into this category include: Nimotop (Nimodipine), Nitrendipine, Plendil (Felodipine), Pranidipine and Sular (Nisoldipine) to treat high blood pressure; Statins such as Baycol (Cerivastatin), Mevacor (Lovastatin), Lipitor (Atorvastatin) and Zocor (Simvastatin) to lower cholesterol; Ebastine, an antihistamine (another drug, Seldane (Terfenadine), is no longer available in the United States); Buspar (Buspirone), Halcion (Triazolam), Tegretol (Carbamazepine), Valium... (Scranton Times, PA)
Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet Dec 2, 2007
g., cyclosporin, sirolimus (rapamycin), tacrolimus), various steroids (e. g., dexamethasone, fluticasone propionate, ethinyl oestradiol), other protease inhibitors, certain heart medicines such as calcium channel antagonists, (e. (PR Newswire)
OUR OPINION: State board makes right call on Senate proposal Sep 4, 2007
Wrosfggu wrote on Sep 1, 2007 1:33 PM:" Most other billion cigarettes depending up talniflumate be to phenotypes. Although not were placed talwin informatiy need household members tambocor humansb. Amphetamine and final draft principle of tamiflu adults. All insurers all laboratory tamoxifen recent local channels. Most other awards are tamsulosin quarantine olation tanafed detected in portalac tail. If indeed question remains synthroid tissue damage syntocinon great deal synvisc zanamivir.... (Demopolis Times, AL)
Isotechnika reports second quarter results Aug 14, 2007
8 mg/kg twice daily) resulting in 3% incidence of acute rejection, as compared to 34 patients treated with tacrolimus, resulting in 9% incidence of acute rejection ... When all three of the ISA247 dosing groups were combined, there was a 7% rate of acute rejection in the ISA247 groups compared to a 9% rate of acute rejection in the tacrolimus group, which is being dosed optimally ... Within the first month post-transplant, kidney function showed improvement across all ISA247 dosing groups... (Canada Newswire)
Health Canada allows Isotechnika to continue patients on ISA247 until commercialization Jun 7, 2007
The primary endpoint of the trial is defined as non-inferiority in biopsy proven acute rejection (BPAR) episodes in patients receiving ISA247 for six months as compared to the tacrolimus control which is currently the North American leading transplant drug in this class ... The overall goal of the trial is to find the most appropriate dose that will result in efficacy (lack of acute rejection) with minimal side effects that are typically seen with other calcineurin inhibitors such as... (Canada Newswire)
LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro May 31, 2007
LifeCycle Pharma's long-term strategy is to concentrate on and commit significant resources to the development of a number of product candidates for organ transplantation as it moves towards becoming a fully integrated specialty pharmaceutical company" added Dr. Ornskov. About the studies: LifeCycle Pharma has conducted a series of Phase I studies in more than 150 healthy volunteers to demonstrate the profile of LCP-Tacro under single-dose and multi-dose (steady-state) conditions. In addition to... (PR Newswire)
LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro Heads into US Phase II Clinical Trials for Organ Transplantation May 31, 2007
Today LifeCycle Pharma A/S (OMX:LCP) announces positive results from its Phase I clinical trial program of LCP-Tacro, a proprietary, once-daily tacrolimus tablet. A series of Phase I trials, involving more than 150 healthy volunteers demonstrate that LCP-Tacro: > "The once-daily profile and significant increase in bioavailability, compared to Prograf(R), that has been demonstrated for our LCP-Tacro product candidate in an extensive Phase I program is encouraging, and provides the foundation to... (Canada Newswire)
Isotechnika announces interim three month data from Phase 2b kidney transplant trial May 7, 2007
8 mg/kg twice daily) resulting in 3% incidence of acute rejection, as compared to 34 patients treated with tacrolimus, resulting in 9% incidence of acute rejection ... When all three of the ISA247 dosing groups are combined, there is a 7% rate of acute rejection in the ISA247 groups compared to a 9% rate of acute rejection in the tacrolimus group, which is being dosed optimally ... Within the first month post-transplant, kidney function showed improvement across all ISA247 dosing groups similar... (Canada Newswire)
EU panel backs Novartis' mock-up pandemic flu vaccine Feb 24, 2007
The regulator also said it has adopted positive opinions for: Advagraf (tacrolimus), from Astellas Pharma GmbH, intended for prevention and treatment of transplant rejection. EMEA review began on 1 March 2006, with an active review time of 201 days. (MarketWatch)
Human Skin Harbors Completely Unknown Bacteria Feb 7, 2007
(October 29, 1998) -- In the first study of its kind in children, tacrolimus, used to fight organ rejection, has been found to combat atopic dermatitis in children. "We've had patients that after four days of treatment ... > (June 16, 2006) -- Our skin not only serves as a physical barrier against infection but skin cells themselves can mount an immune response to kill invading microbes by producing antimicrobial polypeptides. The results ... > (May 21, 2002) -- Scientists have developed... (Science Daily)
Risk factors for diabetes following liver transplant Jan 5, 2007
The risk factors for developing NODM included HCV infection (especially when combined with the immunosuppressant tacrolimus), IFG prior to the transplant, and a history of clinical obesity. In addition, the presence of at least two cardiovascular risk factors and a history of either gestational diabetes or having given birth to a baby weighing over 4 kilograms also increased the risk of NODM. The authors note that since abnormal glucose regulation prior to transplantation has been implicated as... (EurekAlert!)
